List view / Grid view
16 November 2012 | By Pfizer
Pfizer Inc., announced top-line results of a double-blind, placebo-controlled, Phase 3 study...
16 November 2012 | By Roche
The continued use of Avastin based therapy beyond first progression in metastatic colorectal cancer patients leads to survival benefits...
15 November 2012 | By University of Strathclyde
A Nobel Prize winner has been awarded an honorary degree by the University of Strathclyde...
15 November 2012 | By kdm communications limited
Tecan and Promega have developed a turnkey workstation for fully automated extraction of gDNA from whole blood samples...
15 November 2012 | By Gilead Sciences
STaR study findings support Complera as an important single tablet regimen option...
15 November 2012 | By Janssen Global Services
Lilly and Merck are first to join Janssen in this pre-competitive initiative to increase efficiencies in clinical trials...
15 November 2012 | By Gilead Sciences
Two-year results announced ...
14 November 2012 | By Sanofi
Sanofi is pleased to announce the appointment of Dr. Gary J. Nabel...
14 November 2012 | By GlaxoSmithKline
“GSK has been collaborating with the U.S. Department of Health and Human Services..."
14 November 2012 | By AstraZeneca
The European Commission has approved FORXIGA™ (dapagliflozin) tablets...
14 November 2012 | By
Collaboratation on the TEENs registry study...
14 November 2012 | By Novo Nordisk
Novo Nordisk has for the second year in a row just been ranked among the top 25 best multinational workplaces...
14 November 2012 | By Boehringer Ingelheim
Today sees the culmination of weeklong activities at Boehringer Ingelheim...
14 November 2012 | By Novo Nordisk
New numbers on the prevalence of diabetes have been launched...
13 November 2012 | By Boehringer Ingelheim
Boehringer Ingelheim and BaroFold, Inc, have entered into a non-exclusive technology and commercial license option agreement...
